特寶生物(688278.SH):擬向吳階平醫學基金會捐贈200萬元
格隆匯12月1日丨特寶生物(688278.SH)公佈,為切實履行社會責任,進一步支持醫療公益事業,公司決定以自有資金向吳階平醫學基金會捐贈200萬元,用於吳階平醫學基金會開展的公益活動,包括學術交流、教育培訓、臨牀科研支持以及符合基金會章程所規定的公益活動。
除本次對吳階平醫學基金會的捐贈外,截至本公吿出具日,公司最近12個月內累計對外捐贈金額為1106.93萬元,主要捐贈給中國肝炎防治基金會、北京紅心相通公益基金會、北京陳菊梅公益基金會等公益機構用於患者援助、科學研究、救災救援、閩寧協作社會幫扶等活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.